Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin and Metformin for Relapse-Free Survival in HCC
NCT02819869Phase 2Terminated
- Sponsor
- Taipei Medical University WanFang Hospital
- Start
- Aug 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin, metformin in hepatocellular carcinoma (HCC), sponsored by Taipei Medical University WanFang Hospital. Started Aug 2016; status: terminated.
02
Drugs
atorvastatinmetformin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02819869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819869.